comparemela.com

Page 6 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nuvalent Inc (NUVL) Issues Pipeline Update

Nuvalent Inc (NUVL) Issues Pipeline Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones And Reports Fourth Quarter And Full Year 2023 Financial Results

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones And Reports Fourth Quarter And Full Year 2023 Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem…

Adaptimmune: Drug Approval Now Imminent? (NASDAQ:ADAP)

Adaptimmune: Drug Approval Now Imminent? (NASDAQ:ADAP)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Gamida Cell Ltd (NASDAQ:GMDA) Short Interest Up 19 1% in January

Gamida Cell Ltd. (NASDAQ:GMDA – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 7,930,000 shares, a growth of 19.1% from the December 31st total of 6,660,000 shares. Based on an average daily trading volume, of 2,940,000 shares, the short-interest […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.